BLOG

EmeTerm and HeadaTerm are Approved by TGA Australia

EmeTerm and HeadaTerm are Approved by TGA Austr...

WAT Medical is a company that develops safe, effective, and user-friendly wearable medical products.  With a team of devoted staff leading in the field of medical research and development, an...

EmeTerm and HeadaTerm are Approved by TGA Austr...

WAT Medical is a company that develops safe, effective, and user-friendly wearable medical products.  With a team of devoted staff leading in the field of medical research and development, an...

WAT Medical Returns Cruise Show with US Partner VIKAND

WAT Medical Returns Cruise Show with US Partner...

WAT Medical is a company that develops safe, effective, and user-friendly wearable medical products. With a team of devoted staff leading in the field of medical research and development, an...

WAT Medical Returns Cruise Show with US Partner...

WAT Medical is a company that develops safe, effective, and user-friendly wearable medical products. With a team of devoted staff leading in the field of medical research and development, an...

WAT Medical Receives Interview from NHK, Japan’s National Broadcasting Organization

WAT Medical Receives Interview from NHK, Japan’...

NHK is one of the largest broadcasting corporations in Japan, providing international services on numerous TV programs, radio, and the Internet. Currently documenting on the advancements of neuromodulation technologies, in...

WAT Medical Receives Interview from NHK, Japan’...

NHK is one of the largest broadcasting corporations in Japan, providing international services on numerous TV programs, radio, and the Internet. Currently documenting on the advancements of neuromodulation technologies, in...

EmeTerm Anti-Nausea and Vomiting Wristband is FDA Cleared

EmeTerm Anti-Nausea and Vomiting Wristband is F...

WAT Medical's leading product to treat nausea-induced vomiting, EmeTerm, has received its FDA clearance earlier in April. 

EmeTerm Anti-Nausea and Vomiting Wristband is F...

WAT Medical's leading product to treat nausea-induced vomiting, EmeTerm, has received its FDA clearance earlier in April.